Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.

Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, Korelitz B, Kotze PG, Koutroubakis IE, Lakatos PL, Lindsay JO, Magro F, Mantzaris GJ, Ng SC, O'Morain C, Panés J, Parigi T, Ran Z, Rogler G, Rubin DT, Sachar DB, Siegmund B, Steinwurz F, Tysk C, Vavricka S, Verstraete SG, Brezin AP, Haemel AK, Dignass A, Sands BE, Danese S, Peyrin-Biroulet L

Open source

DOI
10.1016/s2468-1253(21)00297-1
Published
2022 Mar
Container
The lancet. Gastroenterology & hepatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-21-00297-1,
  title = {Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.},
  author = {Guillo L and Abreu M and Panaccione R and Sandborn WJ and Azevedo VF and Gensler L and Moghaddam B and Ahuja V and Ali SA and Allez M and Ananthakrishnan AN and Bhattacharya A and Dubinsky M and Griffiths A and Hart A and Korelitz B and Kotze PG and Koutroubakis IE and Lakatos PL and Lindsay JO and Magro F and Mantzaris GJ and Ng SC and O'Morain C and Panés J and Parigi T and Ran Z and Rogler G and Rubin DT and Sachar DB and Siegmund B and Steinwurz F and Tysk C and Vavricka S and Verstraete SG and Brezin AP and Haemel AK and Dignass A and Sands BE and Danese S and Peyrin-Biroulet L},
  year = {2022},
  journal = {The lancet. Gastroenterology \& hepatology},
  doi = {10.1016/s2468-1253(21)00297-1},
  url = {https://doi.org/10.1016/s2468-1253(21)00297-1}
}

RIS

TY  - JOUR
TI  - Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.
AU  - Guillo L
AU  - Abreu M
AU  - Panaccione R
AU  - Sandborn WJ
AU  - Azevedo VF
AU  - Gensler L
AU  - Moghaddam B
AU  - Ahuja V
AU  - Ali SA
AU  - Allez M
AU  - Ananthakrishnan AN
AU  - Bhattacharya A
AU  - Dubinsky M
AU  - Griffiths A
AU  - Hart A
AU  - Korelitz B
AU  - Kotze PG
AU  - Koutroubakis IE
AU  - Lakatos PL
AU  - Lindsay JO
AU  - Magro F
AU  - Mantzaris GJ
AU  - Ng SC
AU  - O'Morain C
AU  - Panés J
AU  - Parigi T
AU  - Ran Z
AU  - Rogler G
AU  - Rubin DT
AU  - Sachar DB
AU  - Siegmund B
AU  - Steinwurz F
AU  - Tysk C
AU  - Vavricka S
AU  - Verstraete SG
AU  - Brezin AP
AU  - Haemel AK
AU  - Dignass A
AU  - Sands BE
AU  - Danese S
AU  - Peyrin-Biroulet L
PY  - 2022
JO  - The lancet. Gastroenterology & hepatology
DO  - 10.1016/s2468-1253(21)00297-1
UR  - https://doi.org/10.1016/s2468-1253(21)00297-1
ER  -

APA

L, G., M, A., R, P., WJ, S., VF, A., L, G., B, M., V, A., SA, A., M, A., AN, A., A, B., M, D., A, G., A, H., B, K., PG, K., IE, K., PL, L., JO, L., F, M., GJ, M., SC, N., C, O., J, P., T, P., Z, R., G, R., DT, R., DB, S., B, S., F, S., C, T., S, V., SG, V., AP, B., AK, H., A, D., BE, S., S, D., & L, P. (2022). Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(21)00297-1

Source records